(4S)-4-(4-METHYLBENZYL)-L-GLUTAMICACID

Modify Date: 2024-01-09 19:12:06

(4S)-4-(4-METHYLBENZYL)-L-GLUTAMICACID Structure
(4S)-4-(4-METHYLBENZYL)-L-GLUTAMICACID structure
Common Name (4S)-4-(4-METHYLBENZYL)-L-GLUTAMICACID
CAS Number 201743-52-4 Molecular Weight 257.12400
Density 1.375 g/cm3 Boiling Point 125-127ºC (0.5 mmHg) ,335.9ºC at 760 mmHg
Molecular Formula C11H13BrO2 Melting Point N/A
MSDS N/A Flash Point 143ºC

 Names

Name (4s)-4-bromomethyl-2-phenyl-1,3-dioxane
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.375 g/cm3
Boiling Point 125-127ºC (0.5 mmHg) ,335.9ºC at 760 mmHg
Molecular Formula C11H13BrO2
Molecular Weight 257.12400
Flash Point 143ºC
Exact Mass 256.01000
PSA 18.46000
LogP 2.88560
Vapour Pressure 0.000226mmHg at 25°C
Index of Refraction 1.538

 MSDS

Name: (4S)-4-Bromomethyl-2-Phenyl-1 3-Dioxane 95% Material Safety Data Sheet
Synonym: None Known
CAS: 201743-52-4
Section 1 - Chemical Product MSDS Name:(4S)-4-Bromomethyl-2-Phenyl-1 3-Dioxane 95% Material Safety Data Sheet
Synonym:None Known

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
201743-52-4 (4S)-4-Bromomethyl-2-Phenyl-1,3-Dioxan 95% unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 201743-52-4: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Viscous liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 125 - 127 deg C @ 0.5mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C11H13BrO2
Molecular Weight: 256.9938

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, light, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Will not occur.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 201743-52-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(4S)-4-Bromomethyl-2-Phenyl-1,3-Dioxane - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 201743-52-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 201743-52-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 201743-52-4 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Hazard Codes Xi: Irritant;
Risk Phrases 36/37/38
Safety Phrases 37/39-26

 Synonyms

MFCD01631668
Top Suppliers:I want be here

Get all suppliers and price by the below link:

(4S)-4-(4-METHYLBENZYL)-L-GLUTAMICACID suppliers

(4S)-4-(4-METHYLBENZYL)-L-GLUTAMICACID price

Related Compounds: More...
(4S)-4-[(4,4-dimethylcyclohexyl)(methylsulfonyl)amino]-N,N-dimethyl-L-prolineamide
1002729-29-4
(4S)-4-(4-Methoxyphenoxy)-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-proline
1354487-10-7
(4S)-4-[(4,4-difluorocyclohexyl)(2,2-dimethylpropanoyl)amino]-N-ethyl-L-prolineamide
1002729-08-9
(4S)-4-(4-Biphenylyloxy)-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-proline
1354485-81-6
(4S)-4-[(4,4-dimethylcyclohexyl)((S)-tetrahydrofuran-2-ylcarbonyl)amino]-N-ethyl-L-prolineamide
1002728-92-8
(4S)-4-[(4,4-difluorocyclohexyl)(2,2-dimethylpropanoyl)amino]-N,N-dimethyl-L-prolineamide
1002729-05-6
(4S)-4-[(4,4-dimethylcyclohexyl)(2,2-dimethylpropanoyl)amino]-N,N-dimethyl-L-prolineamide
1002728-81-5
(4S)-4-(4-Isopropyl-3-methylphenoxy)-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-proline
1354487-85-6
(4S)-4-(4-Bromo-2-chlorophenoxy)-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-proline
1354485-75-8
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
4-Cyclopentyl-2-methylbutanal
1339343-79-1
Benzyl 2-allyl-3-hydroxy-4-nitro-benzoate
1280666-77-4
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
tert-Butyl-DL-alanine
1375289-11-4